estim
pharyng
carriag
rate
neisseria
meningitidi
n
meningitidi
streptococcu
pneumonia
pneumonia
staphylococcu
aureu
aureu
among
australian
hajj
pilgrim
surveil
conduct
two
phase
among
australian
hajj
pilgrim
first
phase
hajj
mina
second
phase
soon
return
home
australia
nasopharyng
oropharyng
swab
taken
particip
test
firstli
nucleic
acid
test
also
standard
cultur
particip
recruit
first
phase
test
posit
pneumonia
receiv
pneumococc
conjug
vaccin
one
test
posit
n
meningitidi
w
nd
phase
sampl
cultur
grew
aureu
methicillin
sensit
grew
n
meningitidi
subcultur
one
serotyp
b
one
neg
unvaccin
pilgrim
grew
pneumonia
rel
high
carriag
pneumonia
littl
meningococc
carriag
found
indic
import
larger
studi
improv
infect
surveil
possibl
vaccin
evalu
hajj
one
world
largest
annual
mass
gather
attract
approxim
million
peopl
year
around
globe
hajj
high
risk
communic
diseas
primarili
due
overcrowd
share
accommod
mingl
local
intern
pilgrim
import
pathogen
arriv
pilgrim
may
result
local
transmiss
infect
within
kingdom
saudi
arabia
ksa
similarli
may
dissemin
infecti
diseas
pilgrim
return
home
respiratori
infect
particular
concern
hajj
transmiss
may
occur
symptomat
individu
asymptomat
carrier
suscept
popul
pharyng
colonis
pathogen
may
contribut
seriou
bacteri
infect
includ
pneumonia
sepsi
mening
localis
meningococc
outbreak
dissemin
link
intern
travel
migrat
attend
hajj
particip
sport
event
intercontinent
spread
serogroup
meningococc
diseas
affect
thousand
hajj
pilgrim
global
mandat
bival
meningococc
c
vaccin
hajj
pilgrim
help
diseas
control
investig
meningococc
outbreak
makkah
ksa
show
extrem
high
meningococc
carriag
rate
among
devote
attend
congreg
prayer
holi
mosqu
follow
hajjassoci
outbreak
neisseria
meningitidi
n
meningitidi
w
visa
entri
ksa
hajj
umrah
pilgrim
chang
requir
quadrival
meningococc
vaccin
cover
serogroup
c
w
current
respiratori
infect
common
ill
hajj
cough
almost
de
rigeur
occur
virtual
hajj
pilgrim
pneumonia
lead
caus
hospit
admiss
hajj
commonest
caus
organ
strepto
coccu
pneumonia
pneumonia
haemophilu
influenza
klebsiella
pneumonia
mycobacterium
tuberculosi
studi
sampl
nare
axilla
groin
open
wound
hajj
pilgrim
carriag
rate
staphylococcu
aureu
aureu
found
methicillin
resist
aureu
mrsa
anoth
studi
four
makkah
hospit
span
twelv
month
includ
hajj
season
mrsa
account
aureu
clinic
isol
inappropri
antimicrobi
use
hajj
could
result
emerg
drugresist
organ
antibiot
resist
respiratori
organ
frequent
isol
hajj
pilgrim
potenti
worldwid
outbreak
infecti
diseas
caus
resist
microorgan
ciprofloxacinresist
n
meningitidi
penicillinresist
pneumonia
mrsa
extendedspectrum
betalactamas
esbl
produc
gram
neg
bacteria
increasingli
recognis
recent
worri
report
acquisit
extendedspectrum
cephalosporinand
colistinresist
salmonella
enterica
return
french
hajj
pilgrim
pharyng
carriag
bacteri
pathogen
among
australian
pilgrim
evalu
therefor
perform
two
pilot
studi
hajj
estim
pharyng
carriag
rate
n
meningitidi
pneumonia
aureu
among
australian
hajj
pilgrim
attend
hajj
assess
antimicrobi
suscept
pattern
investig
possibl
impact
prevent
measur
pretravel
vaccin
facemask
use
enhanc
surveil
conduct
two
phase
among
australian
pilgrim
first
phase
involv
recruit
pilgrim
tent
stay
mina
makkah
ksa
peak
period
hajj
second
phase
involv
recruit
pilgrim
return
hajj
australia
figur
studi
explain
pilgrim
tent
consent
nasopharyng
oropharyng
swab
collect
mina
particip
fifth
day
stay
tent
subset
pilgrim
respiratori
symptom
cough
sore
throat
andor
rhinorrhoea
swab
also
collect
first
day
recruit
follow
collect
flock
swab
place
univers
transport
medium
utm
vircel
swab
transport
approxim
km
ice
collabor
laboratori
makkah
store
ship
similar
condit
test
laboratori
australia
carriag
studi
nest
within
ongo
randomis
control
trial
examin
efficaci
facemask
respiratori
virus
methodolog
publish
within
mo
return
hajj
australian
pilgrim
consent
followup
swab
oropharyng
swab
collect
mosqu
commun
centr
local
event
famili
fun
day
particip
resid
greater
sydney
new
south
wale
pilgrim
oropharyng
swab
obtain
swab
collect
hajj
vortex
ml
utm
nucleic
acid
na
extract
utm
sampl
use
qiagen
viru
mini
kit
qiagen
advanc
xl
instrument
na
elut
final
volum
store
prior
nucleic
acid
test
nat
pneumonia
detect
use
modifi
version
assay
previous
describ
target
basepair
segment
autolysinencod
lyta
gene
forward
primer
revers
primer
probe
fam
tttgccg
baselin
fluoresc
determin
use
fluoresc
reader
stratagen
la
jolla
ca
unit
state
amplif
mastercycl
gradient
thermocycl
eppendorf
hamburg
germani
reaction
mix
amplifi
min
min
cycl
min
one
cycl
end
point
fluoresc
determin
use
posit
sampl
defin
minimum
increas
fluoresc
result
confirm
agaros
gel
electrophoresi
gel
run
volt
min
stain
sybrsaf
n
meningitidi
detect
use
previous
describ
assay
use
singl
amplif
realtim
pcr
target
basepair
segment
meningococc
capsular
transfer
gene
ctra
forward
primer
revers
primer
sampl
n
meningitidi
detect
evalu
use
previous
describ
molecular
serotyp
method
sampl
test
use
five
singleplex
convent
assay
target
differ
region
siad
gene
specif
serotyp
b
c
w
primer
sequenc
list
tabl
reaction
mix
amplifi
min
min
cycl
min
one
cycl
result
product
visualis
agaros
gel
electrophoresi
gel
run
volt
min
stain
sybrsaf
ethic
approv
grant
hunter
new
england
human
research
ethic
committe
hrec
australia
ref
verifi
vaccin
record
pilgrim
data
crosscheck
anoth
ongo
trial
team
separ
ethic
approv
hunter
new
england
hrec
total
pilgrim
recruit
studi
first
phase
hajj
second
phase
hajj
appear
group
figur
median
age
pilgrim
year
rang
women
tabl
one
hundr
nineti
three
sampl
collect
studi
particip
ten
particip
provid
two
swab
first
collect
first
day
mina
symptomat
second
collect
th
day
twentysix
particip
pneumonia
detect
nat
oropharyng
sampl
collect
pilgrim
aureu
isol
methicillin
suscept
tabl
n
meningitidi
isol
two
sampl
subcultur
one
serotyp
b
sensit
benzylpenicillin
cefotaxim
neg
subcultur
pilgrim
report
receiv
quadrival
meningococc
polysaccharid
vaccin
group
report
receiv
meningococc
quadrival
vaccin
travel
hajj
polysaccharid
vaccin
conjug
vaccin
four
recal
vaccin
histori
attend
hajj
like
vaccin
previous
pneumonia
isol
one
pilgrim
could
serotyp
sensit
done
pilgrim
vaccin
pneumococcu
particip
group
report
receiv
pneumococc
vaccin
thirtytwo
report
use
facemask
report
use
facemask
hajj
disclos
whether
use
facemask
pilgrim
use
facemask
aureu
isol
pilgrim
use
facemask
aureu
isol
p
pilgrim
meningococci
isol
report
use
facemask
pilgrim
pneumococcu
recov
disclos
whether
facemask
use
statist
signific
differ
staphylococc
carriag
rate
base
age
year
vs
p
gender
male
vs
femal
vs
p
sixteen
found
pneumococc
carriag
rate
pilgrim
hajj
moder
high
receiv
conjug
pneumococc
vaccin
travel
carriag
similar
irrespect
whether
pneumococc
vaccin
given
reflect
likelihood
mani
pilgrim
alreadi
colonis
vaccin
vaccin
potent
prevent
acquisit
extinguish
carriag
preval
pneumococc
carriag
almost
doubl
rate
report
among
french
pilgrim
earli
phase
hajj
lower
rate
found
day
pilgrim
departur
ksa
studi
pilgrim
begin
end
hajj
memish
et
al
demonstr
although
overal
carriag
rate
pneumococci
among
african
asian
pilgrim
earli
week
hajj
preval
vaccineserotyp
crosssect
investig
overal
carriag
rate
later
phase
hajj
belong
vaccineserotyp
subsequ
investig
conduct
prospect
cohort
studi
hajj
demonstr
pilgrim
p
pilgrim
immedi
conclus
hajj
carri
pneumococci
serotyp
cover
howev
carriag
rate
report
studi
includ
much
lower
high
carriag
rate
found
benkouiten
et
al
among
french
pilgrim
hajj
pneumococc
carriag
rate
posthajj
phase
low
unawar
pneumococc
carriag
studi
pilgrim
return
home
countri
comparison
high
uptak
posthajj
cohort
may
reduc
carriag
rate
could
effect
antibiot
use
report
receiv
antibiot
hajj
also
time
differ
two
month
collect
hajj
posthajj
sampl
enough
time
pilgrim
lost
carriag
hajjassoci
pneumococci
diagnost
test
use
differ
studi
phase
pcr
use
first
phase
standard
cultur
second
phase
may
explain
low
detect
rate
posthajj
phase
uptak
first
cohort
studi
second
cohort
posthajj
higher
report
reflect
pilgrim
particip
vaccin
trial
involv
howev
find
signific
differ
pneumococc
carriag
rate
vaccin
unvaccin
pilgrim
although
signific
lower
vaccin
group
tabl
possibl
small
sampl
size
larg
proport
serotyp
cover
although
serotyp
characteris
perform
pilot
studi
studi
suggest
quarter
half
serotyp
hajj
cover
none
pilgrim
cohort
report
receiv
pneumococc
polysaccharid
vaccin
suffer
chronic
diseas
pneumococc
vaccin
recommend
one
age
year
anoth
studi
overal
pneumococc
polysaccharid
vaccin
uptak
among
australian
pilgrim
rang
intern
studi
shown
overal
uptak
pneumococc
vaccin
hajj
pilgrim
rang
low
meningococc
carriag
rate
hajj
surpris
univers
vaccin
nearli
half
quadrival
conjug
vaccin
hajj
benkouiten
et
al
fail
detect
n
meningitidi
nasal
andor
throat
swab
collect
french
pilgrim
howev
studi
conduct
mina
hajj
among
pilgrim
differ
nation
identifi
carriag
rate
follow
w
epidem
posthajj
meningococc
carriag
rate
less
studi
worldwid
meningococc
w
outbreak
follow
hajj
carriag
among
singaporean
pilgrim
two
week
hajj
serogroup
w
persist
carrier
mo
follow
year
el
bashir
et
al
demonstr
carriag
rate
among
unit
kingdom
pilgrim
serogroup
wk
pilgrim
return
hajj
twenti
one
percent
pilgrim
report
receiv
antibiot
respiratori
ill
hajj
high
rate
antibiot
use
compar
report
particip
studi
ceyhan
et
al
report
return
turkish
hajj
pilgrim
posit
meningococc
carriag
mostli
airportbas
surveil
studi
conduct
thailand
unit
state
demonstr
meningococci
carriag
rate
respect
similar
carriag
rate
contemporari
studi
iran
latter
two
studi
respect
pilgrim
report
use
antibiot
hajj
studi
conduct
iran
kuwait
demonstr
singl
dose
ciprofloxacin
travel
essenti
erad
meningococc
carriag
low
carriag
rate
sever
week
hajj
studi
could
possibl
indic
effect
fairli
high
uptak
conjug
meningococc
vaccin
contrast
report
uptak
conjug
meningococc
vaccin
among
intern
pilgrim
hajj
worldwid
pilgrim
receiv
conjug
vaccin
cost
surveil
studi
conduct
involv
hajj
pilgrim
nation
ashgar
et
al
found
carriag
rate
meningococci
among
arriv
hajj
pilgrim
increas
end
pilgrimag
p
also
report
circul
meningococc
strain
resist
azithromycin
ceftriaxon
ciprofloxacin
levofloxacin
meropenem
rifampicin
due
public
health
signific
monitor
antimicrobi
suscept
clinic
specimen
meningococci
pneumococci
import
particularli
sinc
pilgrim
highrisk
countri
african
mening
belt
routin
given
ciprofloxacin
prophylaxi
arriv
pilgrimag
ksa
transnat
dissemin
multidrug
resist
organ
report
relev
context
pneumococc
diseas
sinc
pneumococc
isol
hajj
penicillin
resist
circul
drug
resist
pneumococci
concern
mass
gather
report
pathogen
multidrug
resist
strain
pneumonia
circul
spain
time
barcelona
olymp
howev
olymp
organis
committe
recommend
pneumococc
vaccin
visitor
today
antibiot
resist
widespread
consid
high
incid
pneumonia
high
carriag
rate
pneumococci
circul
multidrugresist
pneumococci
vaccin
recommend
highrisk
pilgrim
conjug
vaccin
prefer
effect
facemask
use
pharyng
bacteri
carriag
hajj
establish
yet
although
larg
trial
underway
examin
effect
facemask
viral
infect
set
among
healthcar
worker
effect
facemask
pharyng
bacteri
colonis
includ
pneumonia
evalu
signific
effect
observ
even
though
find
signific
effect
facemask
use
pharyng
nasopharyng
carriag
rate
pneumonia
aureu
interestingli
prospect
studi
conduct
netherland
among
pig
farmer
demonstr
use
facemask
significantli
associ
lower
mrsa
nasal
carriag
perhap
larger
facemask
studi
could
demonstr
true
effect
pharyng
colonis
bacteria
found
carriag
rate
aureu
second
posthajj
phase
studi
detect
mrsa
compar
nasal
carriag
rate
among
arriv
intern
pilgrim
among
depart
pilgrim
hajj
similar
nasal
carriag
rate
methicillinsuscept
aureu
elsewher
australia
knowledg
first
australian
carriag
surveil
studi
potenti
pathogen
bacteria
pneumococci
meningococci
aureu
among
hajj
pilgrim
abl
valid
pneumococc
meningococc
conjug
vaccin
uptak
parallel
trial
hajj
roughli
one
five
seven
aureu
isol
mrsa
aureu
cultur
sputum
sampl
isol
among
hajj
pilgrim
respiratori
infect
mrsa
cultur
howev
mrsa
isol
sampl
collect
variou
bodi
site
pilgrim
hajj
limit
studi
includ
rel
small
sampl
size
inconsist
sampl
site
ie
mostli
nasopharyng
first
phase
oropharyng
second
phase
differ
diagnost
method
employ
two
differ
phase
studi
nat
first
phase
studi
phenotyp
method
second
phase
allow
us
compar
two
dataset
directli
differ
studi
design
possibl
make
valid
comparison
report
investig
limit
discuss
narr
synthesi
addit
strain
carriag
organ
studi
especi
assess
potenti
vaccin
prevent
pathogen
h
influenza
pneumococc
isol
serotyp
discord
number
particip
first
second
phase
due
unavail
particip
posthajj
sampl
within
mo
hajj
often
pilgrim
make
side
trip
countri
hajj
return
australia
directli
address
limit
larger
studi
current
underway
conclus
studi
found
moder
high
carriag
rate
pneumonia
amongst
pilgrim
hajj
background
conjug
pneumococc
vaccin
trial
low
meningococc
carriag
rate
pilot
studi
demonstr
larger
studi
feasibl
import
inform
public
health
measur
prevent
transmiss
limit
impact
signific
infecti
diseas
mass
gather
event
annual
hajj
pilgrimag
inform
serotyp
circul
pneumococc
isol
optimis
use
pneumococc
vaccin
pilgrim
multidisciplinari
approach
pharyng
acquisit
pathogen
microorgan
hajj
one
world
largest
mass
gather
known
risk
studi
carriag
rate
common
bacteri
pathogen
among
australian
pilgrim
investig
high
risk
acquir
carriag
potenti
pathogen
bacteria
hajj
author
propos
investig
larger
scale
studi
emphasis
intern
travel
includ
mass
gather
signific
risk
factor
acquisit
subsequ
colonis
infect
bacteria
pilot
studi
demonstr
larger
studi
feasibl
import
inform
public
health
measur
prevent
transmiss
limit
impact
signific
infecti
diseas
mass
gather
event
annual
hajj
pilgrimag
inform
serotyp
circul
pneumococc
isol
optimis
use
pneumococc
vaccin
pilgrim
carriag
harbour
transport
microorgan
exampl
human
bodi
hajj
muslim
pilgrimag
mecca
take
place
last
month
arab
calendar
muslim
expect
make
least
lifetim
afford
one
five
pillar
islam
pilgrimag
pilgrimag
journey
spiritu
signific
pilgrim
person
journey
sacr
place
religi
reason
interest
surveil
studi
carriag
pathogen
bacteria
first
one
among
hajj
pilgrim
